We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Acute Gastroenteritis May Lead to Heart Disease

By HospiMedica International staff writers
Posted on 09 Dec 2010
People who become infected with Escherichia coli have a higher risk of subsequently developing hypertension, heart disease, and kidney problems. More...


Individuals who have become infected with E. coli 0157:H7 and/or Campylobacter and suffered from acute gastroenteritis may have an increased risk of chronic diseases associated with high blood pressure and renal impairment.

An assessment was made at Victoria Hospital, (London, Ontario, Canada), of 4,561 people who had been exposed to a tainted municipal water system in May 2000. The water had been infected with Campylobacter and E. coli 0157:H7 bacteria. The long-term health of 1,977 individuals who had developed gastroenteritis was evaluated as 1,067 of them became ill with acute gastroenteritis, and 378 sought help from a physician. Of the 131 stool samples tested for pathogens, 19% were positive for E. coli O157:H7, 19% were positive for Campylobacter, and 1.5% showed coinfection. This prospective cohort study was conducted from 2002 until 2008.

Structural and functional renal impairment were defined as microalbuminuria (albumin:creatinine ratio greater than 2.0 mg/mmol in men and more than 2.8 mg/mmol in women) and estimated glomerular filtration rate less than 60 mL/min/1.73 m2, respectively. Two classifications of renal impairment were analyzed: the presence of either indicator of renal impairment and the presence of both indicators.

The investigators discovered that those who had developed gastroenteritis symptoms had a 1.3 higher risk of developing hypertension (high blood pressure) compared to those who had not become infected. Renal impairment (kidney problem) risk was 3.4 times higher, and the chances of having a cardiovascular event, such as stroke or heart attack were 2.1 times higher. Recent research suggests that the presence of both structural and functional renal impairment is a stronger predictor of mortality, cardiovascular morbidity, and renal decline than either structural or functional renal impairment alone.

The authors concluded that their findings underline the need for following up individual cases of food or water poisoning by E. coli O157:H7 to prevent or reduce silent progressive vascular injury. These long-term consequences emphasize the importance of ensuring safe food and water supply as a cornerstone of public health.

The study was published November 17, 2010, in the British Medical Journal.

Related Links:

Victoria Hospital


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.